The Contraceptive Implant: An Updated Review of the Evidence

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Obstetrics and Gynecology Reports

• Publication date

  2015-01-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13669-014-0110-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

  2016cited by this paper
• To Decrease Unintended Pregnancies, Decrease Monetary and Nonmonetary Barriers to Hormonal Contraception

  2016cited by this paper
• The continuation rates of long‐acting reversible contraceptives in UK general practice using data from The Health Improvement Network

  2015cited by this paper
• Revisiting menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant

  2015cited by this paper
• Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction.

  2015cited by this paper
• Continuation rates of the subdermal contraceptive Implanon® and associated influencing factors

  2014cited by this paper
• A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system

  2014cited by this paper
• The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.

  2014cited by this paper
• Steroidal contraceptives: effect on bone fractures in women.

  2014cited by this paper
• ARHP Commentary — Thinking (Re)Productively Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach ☆,☆☆

  2014cited by this paper
• Development and testing of an iOS waiting room "app" for contraceptive counseling in a Title X family planning clinic.

  2014cited by this paper
• Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.

  2014cited by this paper
• Acceptability of long-acting, progestin-only contraception in Europe: A two-year prospective, non-interventional study

  2014cited by this paper
• Effect of injectable medroxyprogesterone acetate and etonogestrel implants on GABA-A and serotonin receptors in white and gray matter of the brain: experimental study in rats

  2014cited by this paper
• Management of etonogestrel subdermal implant-related bleeding.

  2014cited by this paper
• Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

  2014cited by this paper
• Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use

  2013cited by this paper
• Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth.

  2013cited by this paper
• Factors associated with provision of long-acting reversible contraception among adolescent health care providers.

  2013cited by this paper
• Weight change at 12 months in users of three progestin-only contraceptive methods.

  2013cited by this paper
• The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review.

  2013cited by this paper
• Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.

  2013cited by this paper
• "I think it depends on the body, with mine it didn't work": explaining young women's contraceptive implant removal.

  2013cited by this paper
• Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.

  2013cited by this paper
• Hormonal contraceptives for contraception in overweight or obese women.

  2013cited by this paper
• Twenty-Four–Month Continuation of Reversible Contraception

  2013cited by this paper
• Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate.

  2013cited by this paper
• Association of body mass index with removal of etonogestrel subdermal implant.

  2013cited by this paper
• Preventing unintended pregnancies by providing no-cost contraception.

  2013cited by this paper
• Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

  2012cited by this paper
• Pharmacokinetics of the etonogestrel contraceptive implant in obese women.

  2012cited by this paper
• Contraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women

  2012cited by this paper
• Continuation of the Etonogestrel Implant in Women Undergoing Immediate Postabortion Placement

  2012cited by this paper
• Bioequivalence and X-Ray Visibility of a Radiopaque Etonogestrel Implant versus a Non-Radiopaque Implant

  2012cited by this paper
• Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?

  2012cited by this paper
• Contraceptive failure in the United States.

  2012cited by this paper
• Effectiveness of long-acting reversible contraception.

  2012cited by this paper
• Neuropathy associated with etonogestrel implant insertion.

  2012cited by this paper
• Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.

  2012cited by this paper
• Changes in use of long-acting contraceptive methods in the United States, 2007-2009.

  2012cited by this paper
• Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.

  2012cited by this paper
• Lactogenesis After Early Postpartum Use of the Contraceptive Implant: A Randomized Controlled Trial

  2011cited by this paper
• Bleeding related to etonogestrel subdermal implant in a US population.

  2011cited by this paper
• Continuation and Satisfaction of Reversible Contraception

  2011cited by this paper
• Strategies to improve adherence and acceptability of hormonal methods of contraception.

  2011cited by this paper
• The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.

  2011cited by this paper
• Family planning training in US family medicine residencies.

  2011cited by this paper
• One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.

  2011cited by this paper
• Progestin-only contraceptives: effects on weight.

  2011cited by this paper
• ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives.

  2010cited by this paper
• Health care providers' knowledge about contraceptive evidence: a barrier to quality family planning care?

  2010cited by this paper
• Recommendations for intrauterine contraception: a randomized trial of the effects of patients' race/ethnicity and socioeconomic status.

  2010cited by this paper
• Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years

  2010cited by this paper
• From Breakthrough to Bust: The Brief Life of Norplant, the Contraceptive Implant

  2010cited by this paper
• Progestogen-only contraceptive use among breastfeeding women: a systematic review.

  2010cited by this paper
• U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition

  2010cited by this paper
• Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.

  2009cited by this paper
• The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study

  2009cited by this paper
• Cost savings from the provision of specific methods of contraception in a publicly funded program.

  2009cited by this paper
• Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study.

  2009cited by this paper
• Effects of the progestagen‐only contraceptive implant Implanon® on cardiovascular risk factors

  2008cited by this paper
• The contraceptive efficacy of Implanon®: A review of clinical trials and marketing experience

  2008cited by this paper
• Effect of the subdermal contraceptive etonogestrel implant (Implanon®) on biochemical and hormonal parameters (three years follow-up)

  2008cited by this paper
• Looking inward: provider-based barriers to contraception among teens and young adults.

  2008cited by this paper
• Assessment of Implanon insertion and removal.

  2008cited by this paper
• Tolerability and clinical safety of Implanon®

  2008cited by this paper
• The effects of Implanon® on menstrual bleeding patterns

  2008cited by this paper
• Increasing intrauterine contraception use by reducing barriers to post-abortal and interval insertion.

  2008cited by this paper
• The potential of long-acting reversible contraception to decrease unintended pregnancy.

  2008cited by this paper
• Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases.

  2007cited by this paper
• Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.

  2007cited by this paper
• A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants

  2007cited by this paper
• [A new complication of contraceptive hormonal implant: two cases of lesions of the ulnar nerve at the arm level. Gynecol Obstet Fertil 2005;33:322-5].

  2006cited by this paper
• The role of progestins in treating the pain of endometriosis.

  2006cited by this paper
• Migration of Implanon®

  2006cited by this paper
• A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants.

  2006cited by this paper
• Effects of a subdermal levonorgestrel contraceptive implant (Norplant) on serum cholesterol, triglycerides, ALT and AST in Iranian women.

  2006cited by this paper
• Une nouvelle complication de l'implant hormonal contraceptif : l'atteinte du nerf ulnaire au bras. À propos de deux cas

  2005cited by this paper
• [A new complication of contraceptive hormonal implant: about two cases of lesions of the ulnar nerve at the arm level].

  2005cited by this paper
• Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.

  2005cited by this paper
• Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant

  2005cited by this paper
• Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.

  2005cited by this paper
• Contraceptive failure in the United States.

  2004cited by this paper
• Spontaneous snapping of an Implanon® in two halves in situ

  2003cited by this paper
• Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials.

  2002cited by this paper
• Mechanisms that explain the contraceptive action of progestin implants for women.

  2002influential reference
• Selected practice recommendations for contraceptive use

  2002cited by this paper
• The pharmacokinetics and pharmacodynamics of Implanon®, a single-rod etonogestrel contraceptive implant

  2000cited by this paper
• Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

  1999cited by this paper
• A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group.

  1999cited by this paper
• A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for less than or equal to 4 years.

  1999cited by this paper
• Risk of idiopathic venous thromboembolism in users of progestagens alone.

  1999cited by this paper
• A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.

  1999cited by this paper
• A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for < or = 4 years.

  1999cited by this paper
• A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China.

  1999cited by this paper
• Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

  1998cited by this paper
• Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.

  1998cited by this paper
• A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand.

  1998cited by this paper
• Effects on the hemostatic system and liver function in relation to Implanon ® and Norplant ® 1 1 Norplant is a registered trademark of the Population Council, Inc., New York, New York

  1998cited by this paper
• Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.

  1998cited by this paper

• Update on Current Hormonal and Non-Hormonal Contraceptive Options in Non-Human Primates

  2024cites this paper
• Long-acting reversible contraception with etonogestrel implants in female macaques (Macaca mulatta and Macaca fascicularis)

  2024cites this paper
• The effect of circulating iron on barrier integrity of primary human endothelial cells

  2023cites this paper
• Elderly’s preferences towards rehabilitation robot appearance using electroencephalogram signal

  2021cites this paper
• Physiological measurements in social acceptance of self driving technologies

  2021cites this paper
• In vivo human brain expression of histone deacetylases in bipolar disorder

  2020cites this paper
• Do modern family planning methods impact women’s quality of life? Jordanian women’s perspective

  2019cites this paper
• Asymmetric hemisphere activation in tenderness: evidence from EEG signals

  2018cites this paper
• Long acting reversible contraception

  2010cites this paper